Improved glycemic control and platelet function abnormalities in diabetic patients with microvascular disease

Metabolism: Clinical and Experimental

Volumn 49, Issue 1, 2000, Pages 88-91

  Roshan, Bijan ^a,b,c,d,e,f   Tofler, Geoffrey H ^a,b,c,d,e,f   Weinrauch, Larry A ^a,b,c,d,e,f   Gleason, Ray E ^a,b,c,d,e,f   Keough, Joanne A ^a,b,c,d,e,f   Lipinska, Izabela ^a,b,c,d,e,f   Lee, Annette T ^a,b,c,d,e,f   d’Elia, John A ^a,b,c,d,e,f  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Center for Cardiovascular Disease Prevention   (United States)

^c MOUNT AUBURN HOSPITAL   (United States)

^d JOSLIN DIABETES CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; GLUCOSE; INSULIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DIABETIC MICROANGIOPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0033957937     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(00)90813-8     Document Type: Article

References (55)

1. Oskarsson HJ, Hofmeyer TG: Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation. J Am Coll Cardiol 27:1464-1470, 1996
2. Oskarsson HJ, Hofmeyer TG: Diabetic human platelets release a substance that inhibits platelet-mediated vasodilation. Am J Physiol 273:H371-H379, 1997
3. Shaw S, Pegrum GD, Wolff SS, et al: Platelet adhesiveness in diabetes mellitus. J Clin Pathol 20:845-847, 1967
4. Mayne EE, Bridges JM, Weaver JA: Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitus. Diabetologia 6:436-440, 1970
5. Fuller JH, Keen H, Jarrett RJ, et al: Haemostatic variables associated with diabetes and its complications. BMJ 2:964-966, 1979
6. Badawi H, El-Sawy M, Mikhail M, et al: Platelets, coagulation and fibrinolysis in diabetic and non-diabetic patients with quiescent coronary heart disease. Angiology 21:511-519, 1970
7. Hellem AJ: Adenosine diphosphate induced platelet adhesiveness in diabetes mellitus with complications. Acta Med Scand 190:291-295, 1971
8. Mayne EE, Bridges JM, Weaver JA: Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitus. Diabetologia 6:436-440, 1970
9. Odegaard HE, Skalhegg BA, Hellem AJ: Increased activity of anti-Willebrand factor' in diabetic plasma. Thromb Diath Haemorrh 11:27-37, 1964
10. Jones RL, Peterson CM: Hematologic alterations in diabetes mellitus. Am J Med 70:339-352, 1981
11. O'Malley BC, Temperly WR, Ward JD, et al: Platelet abnormalities in diabetic peripheral neuropathy. Lancet 2:1274-1276, 1975
12. Kwaan HC, Colwell JA, Cruz S, et al: Increased platelet aggregation in diabetes mellitus. J Lab Clin Med 80:236-246, 1972
13. Colwell JA, Halushka PV, Sarji KE, et al: Correlation of platelet aggregation, plasma factor and activity, and megathrombocytes in diabetic subjects with and without vascular disease. Metabolism 26:279-285, 1977
14. Heath H, Bridgden WD, Canever JV, et al: Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 7:308-315, 1971
15. Sagel J, Colwell JA, Crook L: Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 82:733-738, 1975
16. Gensini GF, Abbate R, Favilla S, et al: Changes of platelet function and blood clotting in diabetes mellitus. Thromb Haemost 42:983-993, 1979
17. Butkus A, Skriska VA, Schumaker P: Thromboxane production and platelet aggregation in diabetic patients with clinical complications. Thromb Res 19:211-223, 1980
18. Catalano DG, Averna M, Notarbartolo A, et al: Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 322:1769-1774, 1990
19. Winocour PD: Platelet abnormalities in diabetes mellitus. Diabetes 41:26-31, 1992 (suppl 2)
20. Shukla SD, Paul A, Klachko DM: Hypersensitivity of diabetic human platelets to platelet activating factor. Thromb Res 66:239-246, 1992
21. Halushka PV, Rogers RC, Loadholt CB, et al: Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 97:87-96, 1981
22. Aoki I, Shimoyama K, Aoki N, et al: Platelet-dependent thrombin generation in patients with diabetes mellitus: Effect of glycemic control on coagulability in diabetes. J Am Coll Cardiol 27:560-566, 1996
23. Burrows AW, Chavin S, Hockaday TDR: Plasma beta-thromboglobulin concentrations in diabetes mellitus. Lancet 1:235-237, 1978
24. Lowe GDO, Ghafour IM, Belch JJF, et al: Increased blood viscosity in diabetic proliferative retinopathy. Diabetes Res 3:67-70, 1986
25. Lufkin EG, Fass DN, O'Fallon WM, et al: Increased von Willebrand factor in diabetes mellitus. Metabolism 28:63-66, 1979
26. Stehouwer CD, Strose ES, Hackeng WH, et al: Von Willebrand factor and development of diabetic nephropathy in IDDM. Diabetes 40:971-976, 1991
27. Schmidt AM, Crandall J, Hori O, et al: Elevated levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: A marker of vascular dysfunction and progressive vascular disease. Br J Haematol 92:747-750, 1996
28. Poon PYW, Dornan TL, Orde-Peckar C, et al: Blood viscosity, glycemic control and retinopathy in insulin-dependent diabetes. Clin Sci (Colch) 63:211-216, 1982
29. Rosove MH, Frank HJL, Harwig SS: Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved short-term glycemic control in diabetes mellitus. Diabetes Care 7:174-179, 1984
30. Small M, Lowe GD, MacCuish AC, et al: Thrombin and plasmin activity in diabetes mellitus and their association with glycaemic control. Q J Med 65:1025-1031, 1987
31. Muhlhauser I, Schernthaner G, Silberbauer K, et al: Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases. Artery 8:73-79, 1980
32. Betteridge DJ, Zahavi J, Jones NAG, et al: Platelet function in diabetes in relationship to complications, glycosylated haemoglobin and serum lipoproteins. Eur J Clin Invest 111:272-277, 1981
33. Paulsen EP, McChung NM, Sabio H: Some characteristics of spontaneous platelet aggregation in young insulin dependent diabetic subjects. Horm Metab Res Suppl 11:15-21, 1981
34. Davi G, Gresele P, Violi F, et al: Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vitro. Evidence from the study of peripheral arterial disease. Circulation 96:69-75, 1997
35. Mazzanti L, Rabini RA, Fumelli P, et al: Altered platelet membrane dynamic properties in type 1 diabetes. Diabetes 46:2069-2074, 1997
36. Vicari AM, et al: Deranged platelet calcium homeostasis in diabetic patients with end-stage renal failure. Diabetes Care 19:1062-1066, 1996
37. Watala C, Gwozdzinski K, Pluskota E, et al: Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets. Thromb Haemost 75:147-153, 1996
38. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
39. Eurodiab IDDM Complications Study Group: Microvascular and acute complications in IDDM patients: The Eurodiab Complications Study. Diabetologia 37:278-285, 1994
40. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
41. Weinrauch LA, Kennedy FP, Gleason RE, et al: Relationship between autonomic function and progression of renal disease in diabetic proteinuria. Am J Hypertens 11:302-308, 1998
42. Weinrauch LA, Gleason RE, Keough J, et al: Relationship between autonomic function and plasma fibrinogen, viscosity, and elements of fibrinolytic activity in diabetic nephropathy. Am J Hypertens 10:454-461, 1997
43. Aoki TT, Benbarka M, Okimura MC, et al: Long-term intermittent intravenous insulin therapy and type 1 diabetes. Lancet 432:515-518, 1993
44. Dailey G, Boden G, Creech R, et al: Weekly pulsatile IV insulin treatments appear to slow progression of diabetic nephropathy. Diabetes 44:24A, 1995 (abstr)
45. Penny W, Weinstein M, Salzman EW, et al: Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics. Circulation 83:1630-1636, 1991
46. Born GVR: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927-929, 1962
47. Makita Z, Vlassara H, Cerami A, et al: Immunochemical detection of advanced glycosylation end-products in vivo. J Biol Chem 8:5133-5138, 1992
48. Davi G, Averna M, Catalano I, et al: Platelet function in patients with type 2 diabetes mellitus: The effect of glycemic control. Diabetes Res 10:7-39, 1989
49. El Khawand C, Jamart J, Donckier J, et al: Hemostasis variables in type 1 diabetic patients without demonstrable vascular complications. Diabetes Care 16:1137-1145, 1993
50. Wanger B, Fashing P, Schneider B, et al: Platelet and endothelial function in patients with insulin dependent diabetes mellitus with excellent, good, or poor metabolic control. Microvasc Res 52:183-187, 1996
51. Mayfield RK, Halushka PV, Wohltmann HJ, et al: Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes 34:1127-1133, 1985
52. Turk Z, Flego I, Kerum G: Platelet aggregation in type I diabetes without microvascular disease during continuous subcutaneous insulin infusion. Horm Metab Res 28:95-100, 1996
53. McDonald JWD, Dupre J, Rodger NW, et al: Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions. Thromb Res 28:705-712, 1982
54. Christiansen JS, Ingerslev J, Bernvil SS, et al: Near normoglycemia for 1 year has no effect on platelet reactivity, factor VIII, and von Willebrand factor in insulin-dependent diabetes mellitus: A controlled trial. J Diabetes Complications 1:100-106, 1987
55. Keaney JF, Loscalzo J: Diabetes, oxidative stress, and platelet activation. Circulation 99:189-191, 1999